Cboe Global Markets (CBOE) Amends and Restates €1.2 Billion Cboe Clear Europe Credit Facility, Effective June 26, 2026

Cboe Global Markets, Inc. (NASDAQ: CBOE) disclosed in a Form 8-K filed with the U.S. Securities and Exchange Commission that it entered into an Amendment and Restatement Agreement on June 23, 2026, becoming effective as of June 26, 2026. The agreement amends and restates the credit facility supporting Cboe Clear Europe N.V., the company's European clearing house, which was originally dated July 1, 2020. The amended facility was arranged with Bank of America Europe Designated Activity Company and Citibank N.A., London Branch. Under the restated terms, Cboe extended the term of the Facility Agreement to June 25, 2027, and maintained the aggregate committed amount at €1.2 billion. The facility also preserves an accordion feature that allows the aggregate commitment to be increased to €1.7 billion. According to the filing, the parties additionally modified certain provisions to incorporate updates in applicable laws and regulations. The facility is a liquidity backstop tied to the operation of Cboe Clear Europe rather than corporate borrowing for general purposes. Central counterparty clearing houses are required to hold substantial committed liquidity resources to meet settlement and default-management obligations, so renewing and extending this line is a routine but operationally important piece of Cboe's European market infrastructure. Cboe Clear Europe has been central to the company's strategy of expanding clearing services across European equities and, increasingly, securities financing transactions. For investors, the amendment is best read as a housekeeping and continuity measure rather than a strategic shift or a sign of financial stress. The commitment size and accordion capacity were held flat, signaling that the company sees its existing liquidity envelope as adequate, and the one-year extension preserves uninterrupted access to backup funding for the clearing business. There is no indication that the facility was drawn or that pricing materially changed in a way that would affect Cboe's interest expense or balance sheet leverage. Cboe remains in solid financial health, having reported strong results in recent quarters driven by record options and derivatives volumes. Against that backdrop, the renewal of a committed liquidity facility for its clearing arm is unlikely to move the stock and carries limited near-term financial impact. It does, however, reaffirm the stability of the credit relationships underpinning Cboe's growing European clearing footprint. The full terms of the Amendment and Restatement Agreement are contained in the Form 8-K and accompanying exhibit filed with the SEC. Because the changes are largely administrative—extending term, maintaining capacity, and updating regulatory language—the disclosure is regulatory in nature and neutral for shareholders.